RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fuso Pharmaceutical Industries Stock

Fuso Pharmaceutical Industries ROA 2024

Fuso Pharmaceutical Industries ROA

0.02

Ticker

4538.T

ISIN

JP3823600006

In 2024, Fuso Pharmaceutical Industries's return on assets (ROA) was 0.02, a -15.07% increase from the 0.02 ROA in the previous year.

Fuso Pharmaceutical Industries Aktienanalyse

What does Fuso Pharmaceutical Industries do?

Fuso Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Fuso Pharmaceutical Industries's Return on Assets (ROA)

Fuso Pharmaceutical Industries's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Fuso Pharmaceutical Industries's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Fuso Pharmaceutical Industries's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Fuso Pharmaceutical Industries’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Fuso Pharmaceutical Industries stock

What is the Return on Assets (ROA) of Fuso Pharmaceutical Industries this year?

The Return on Assets (ROA) of Fuso Pharmaceutical Industries is 0.02 undefined this year.

What was the ROA of Fuso Pharmaceutical Industries compared to the previous year?

The ROA of Fuso Pharmaceutical Industries has increased by -15.07% compared to the previous year.

What consequences do high ROA have for investors of Fuso Pharmaceutical Industries?

A high ROA is advantageous for investors of Fuso Pharmaceutical Industries, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Fuso Pharmaceutical Industries?

A low ROA can be unfavorable for investors of Fuso Pharmaceutical Industries as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Fuso Pharmaceutical Industries affect the company?

An increase in ROA of Fuso Pharmaceutical Industries can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Fuso Pharmaceutical Industries impact the company?

A reduction in the ROA of Fuso Pharmaceutical Industries can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Fuso Pharmaceutical Industries?

Some factors that can influence the ROA of Fuso Pharmaceutical Industries include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Fuso Pharmaceutical Industries important for investors?

The ROA of Fuso Pharmaceutical Industries is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Fuso Pharmaceutical Industries take to improve ROA?

To improve ROA, Fuso Pharmaceutical Industries can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Fuso Pharmaceutical Industries pay?

Over the past 12 months, Fuso Pharmaceutical Industries paid a dividend of 75 JPY . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Fuso Pharmaceutical Industries is expected to pay a dividend of 75 JPY.

What is the dividend yield of Fuso Pharmaceutical Industries?

The current dividend yield of Fuso Pharmaceutical Industries is 3.42 %.

When does Fuso Pharmaceutical Industries pay dividends?

Fuso Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Fuso Pharmaceutical Industries?

Fuso Pharmaceutical Industries paid dividends every year for the past 20 years.

What is the dividend of Fuso Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 75 JPY are expected. This corresponds to a dividend yield of 3.42 %.

In which sector is Fuso Pharmaceutical Industries located?

Fuso Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuso Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuso Pharmaceutical Industries from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Fuso Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Fuso Pharmaceutical Industries in the year 2023?

In the year 2023, Fuso Pharmaceutical Industries distributed 75 JPY as dividends.

In which currency does Fuso Pharmaceutical Industries pay out the dividend?

The dividends of Fuso Pharmaceutical Industries are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuso Pharmaceutical Industries

Our stock analysis for Fuso Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuso Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.